Clinical significance of the FV:Q506 mutation in unselected oncology patients
- 31 October 1996
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 101 (4) , 406-412
- https://doi.org/10.1016/s0002-9343(96)00235-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophiliaBlood, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Hypercoagulable StatesAnnals of Internal Medicine, 1993
- Inherited predisposition to thrombosisCell, 1993
- Deficiencies of Coagulation-Inhibiting and Fibrinolytic Proteins in Outpatients with Deep-Vein ThrombosisNew England Journal of Medicine, 1990
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988